Biotech · Private company · Seattle, WA, US
Virtici, LLC
Track this companyFree. Adds Virtici, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards10
- A Novel Preventative and Treatment for Klebsiella Pneumoniae InfectionFiscal year 2026 · $306.5KNIH RePORTER 1R43AI188659-01A1 · fetched Nov 12, 2026
- A Novel Sublingual Vaccine for Preventing andTreating PeriodontitisFiscal year 2026 · $306.5KNIH RePORTER 1R43DE036133-01 · fetched Nov 12, 2026
- A Novel Immune-modulating Probiotic for Treating Rheumatoid Arthritis Fiscal year 2026 · $300.2KNIH RePORTER 1R44AI188778-01A1 · fetched Nov 12, 2026
- A Bioengineered Probiotic for Resetting Immune Function in Rheumatoid ArthritisFiscal year 2026 · $306.3KNIH RePORTER 1R44AR087173-01 · fetched Nov 12, 2026
- A Novel Anti-infective Therapy for Treating PeriodontitisFiscal year 2026 · $308.1KNIH RePORTER 5R43DE034614-02 · fetched Nov 12, 2026
- A Novel Bispecific Antibody for the Treatment of Idiopathic Pulmonary FibrosisFiscal year 2026 · $903.6KNIH RePORTER 5R44HL164202-05 · fetched Nov 12, 2026
- A Novel Anti-infective Therapy for Treating PeriodontitisFiscal year 2025 · $309KNIH RePORTER 1R43DE034614-01 · fetched Nov 12, 2026
- A Novel Peptide for the Oral Treatment and Prevention of P. Gingivalis InfectionFiscal year 2025 · $698.7KNIH RePORTER 5R44DE033568-02 · fetched Nov 12, 2026
- A Novel Bispecific Antibody for the Treatment of Idiopathic Pulmonary FibrosisFiscal year 2025 · $1MNIH RePORTER 5R44HL164202-04 · fetched Nov 12, 2026
- A Novel Blood Test for Early Diagnosis of Frontotemporal Lobar DegenerationFiscal year 2024 · $700KNIH RePORTER 1R43NS139747-01 · fetched Nov 12, 2026